Mass. General team generates stem-cell derived heart muscle in cell-free human cardiac matrix
Massachusetts General Hospital (MGH) researchers have taken some initial steps toward the creation of bioengineered human hearts using donor hearts stripped of components that would generate an immune response and cardiac muscle cells generated from induced pluripotent stem cells (iPSCs), which could come from a potential recipient. The investigators described their accomplishments – which include developing an automated bioreactor system capable of supporting a whole human heart during the recellularization process — earlier this year in Circulation Research.
“Generating functional cardiac tissue involves meeting several challenges,” says Jacques Guyette, PhD, of the MGH Center for Regenerative Medicine (CRM), lead author of the report. “These include providing a structural scaffold that is able to support cardiac function, a supply of specialized cardiac cells, and a supportive environment in which cells can repopulate the scaffold to form mature tissue capable of handling complex cardiac functions.”
The research team is led by Harald Ott, MD, of the MGH CRM and the Department of Surgery, senior author of the paper. In 2008, Ott developed a procedure for stripping the living cells from a donor organ with a detergent solution and then repopulating the remaining extracellular matrix scaffold with organ-appropriate types of cells. Since then his team has used the approach to generate functional rat kidneys and lungs and has decellularized large-animal hearts, lungs and kidneys. This report is the first to conduct a detailed analysis of the matrix scaffold remaining after decellularization of whole human hearts, along with recellularization of the cardiac matrix in three-dimensional and whole-heart formats.
The study included 73 human hearts that had been donated through the New England Organ Bank, determined to be unsuitable for transplantation and recovered under research consent. Using a scaled-up version of the process originally developed in rat hearts, the team decellularized hearts from both brain-dead donors and from those who had undergone cardiac death. Detailed characterization of the remaining cardiac scaffolds confirmed a high retention of matrix proteins and structure free of cardiac cells, the preservation of coronary vascular and microvascular structures, as well as freedom from human leukocyte antigens that could induce rejection. There was little difference between the reactions of organs from the two donor groups to the complex decellularization process.
Instead of using genetic manipulation to generate iPSCs from adult cells, the team used a newer method to reprogram skin cells with messenger RNA factors, which should be both more efficient and less likely to run into regulatory hurdles. They then induced the pluripotent cells to differentiate into cardiac muscle cells or cardiomyocytes, documenting patterns of gene expression that reflected developmental milestones and generating cells in sufficient quantity for possible clinical application. Cardiomyocytes were then reseeded into three-dimensional matrix tissue, first into thin matrix slices and then into 15 mm fibers, which developed into spontaneously contracting tissue after several days in culture.
The last step reflected the first regeneration of human heart muscle from pluripotent stem cells within a cell-free, human whole-heart matrix. The team delivered about 500 million iPSC-derived cardiomyocytes into the left ventricular wall of decellularized hearts. The organs were mounted for 14 days in an automated bioreactor system developed by the MGH team that both perfused the organ with nutrient solution and applied environmental stressors such as ventricular pressure to reproduce conditions within a living heart. Analysis of the regenerated tissue found dense regions of iPSC-derived cells that had the appearance of immature cardiac muscle tissue and demonstrated functional contraction in response to electrical stimulation.
“Regenerating a whole heart is most certainly a long-term goal that is several years away, so we are currently working on engineering a functional myocardial patch that could replace cardiac tissue damaged due a heart attack or heart failure,” says Guyette. “Among the next steps that we are pursuing are improving methods to generate even more cardiac cells – recellularizing a whole heart would take tens of billions — optimizing bioreactor-based culture techniques to improve the maturation and function of engineered cardiac tissue, and electronically integrating regenerated tissue to function within the recipient’s heart.”
Team leader Ott, an assistant professor of Surgery at Harvard Medical School, adds, “Generating personalized functional myocardium from patient-derived cells is an important step towards novel device-engineering strategies and will potentially enable patient-specific disease modeling and therapeutic discovery. Our team is excited to further develop both of these strategies in future projects.”
The Latest on: Bioengineered human hearts
via Google News
The Latest on: Bioengineered human hearts
- Insomniac’s Stormland Is An Epic VR Sci-Fi RPG With A Ton Of Hearton November 16, 2019 at 2:24 pm
It’s a bioengineered robotic Superman! I’m in the middle of a high-speed surf across ... The story, while brief, does an excellent job of building an emotional relationship between you and the in-game ...
- Bioengineered Blood Vessels Can Grow Inside Animalson September 26, 2019 at 5:00 pm
Made from skin cells, the grafts successfully replaced part of the pulmonary artery, which carries blood from the heart to the lungs. If these bioengineered arteries ... the artificial vessels can be ...
- Two new Pfizer-coauthored studies validate Novoheart’s pioneering human bioengineered heart tissues and chambers for improving drug developmenton September 8, 2019 at 9:05 pm
These peer-reviewed publications from our ongoing collaborations with Pfizer showcase the robustness of our bioengineered heart constructs as next-generation, human-specific drug screening and disease ...
- Scientists take major step in 3D bioprinting functional organson August 2, 2019 at 6:02 am
There are still many challenges to overcome to get us to bioengineered 3D organs ... The FRESH 3D bioprinted hearts were based on human MRI and accurately reproduced patient-specific anatomical ...
- FRESH 3D printing used to rebuild functional components of human hearton August 1, 2019 at 11:42 am
"There are still many challenges to overcome to get us to bioengineered 3D organs ... The FRESH 3D bioprinted hearts were based on human MRI and accurately reproduced patient-specific anatomical ...
- Miromatrix spins out a company, steps up focus on bioengineered organs for humanson July 9, 2019 at 6:47 pm
Miromatrix has spent more than a decade researching how to make bioengineered organs for human transplants. Now, the company with University of Minnesota roots is accelerating that work after spinning ...
- Scientists use miniature hearts to test potential new drugson March 29, 2019 at 5:41 am
a group of Australian scientists recently conducted the first-ever screening of potential heart regeneration drugs by using bioengineered human heart muscle. The four-year study was published in the ...
- Miniature hearts can be helpful in testing potential new drugson March 29, 2019 at 1:30 am
“Currently potential new drugs are tested on heart cells or in mice but those tests don`t always accurately replicate the effects on human hearts,” Hudson said. According to the study author, 90 per ...
via Bing News